申请人:TAKEDA CHEMICAL INDUSTRIES, LTD.
公开号:EP0641776A2
公开(公告)日:1995-03-08
A compound represented by the formula:
wherein R1 and R2 are the same or different, an acyl group; R3, R4, R6 and R7 are the same or different, hydrogen or an alkyl group; R5 is hydrogen, an alkyl group or a hydroxyl group which may optionally be protected, or R4 and R5 are combined to form a chemical bond; X is a carbonyl group or a sulfonyl group; Y is an amino acid sequence consisting of 1 to 7 amino acid residues which may optionally be protected and having optionally an intervening -SO2NH-; n is an integer of 0 to 2, or a salt thereof.
The compound or salt thereof of the present invention possesses immunoenhancing activity and platelet reduction recovery activity, and can be used as a prophylactic/therapeutic agent for leukocytopenia in cancer chemotherapy or radiotherapy, as an immunoenhancing agent in bone marrow transplantation therapy and the treatment of osteomyelodysplasia and aplastic anemia, and as a prophylactic/therapeutic agent for thrombocytopenia.
一种由式表示的化合物:
其中,R1和R2相同或不同,为酰基;R3、R4、R6和R7相同或不同,为氢或烷基;R5为氢、烷基或羟基,可选择被保护,或R4和R5结合形成化学键;X为羰基或磺酰基;Y为由1至7个氨基酸残基组成的氨基酸序列,可选择被保护,中间可选择有-SO2NH-;n为0至2的整数,或其盐。
本发明的化合物或其盐具有免疫增强活性和血小板减少恢复活性,可用作癌症化疗或放疗中白细胞减少症的预防/治疗剂、骨髓移植治疗和骨髓增生异常及再生障碍性贫血治疗中的免疫增强剂,以及血小板减少症的预防/治疗剂。